Drug Trial Radar · NCT07431177
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
210
Planned (sponsor's estimate)
Start
Mar 9, 2026
Primary completion
Jun 6, 2028
Study completion Jan 28, 2030
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Feb 24, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this multicenter, randomized, double-blind, placebo-controlled Phase 2b study is to investigate the safety and efficacy of GIA632 in participants with NSV and to identify the optimal dose to be promoted into the confirmatory Phase 3 program.
Conditions
- Non-segmental Vitiligo
Interventions
GIA632Drug
GIA632 will be administered during the 48-week core period.
PlaceboDrug
Placebo will be administered during the 48-week core period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage change from baseline in Facial Vitiligo Area Scoring Index (F-VASI) score.Time frame: Baseline, Week 24
Locations
85 sites in 12 countries. Site status is shown where the registry gives one.
Cahaba Derm and skin hlth ctr 27
Birmingham, Alabama · Recruiting
First OC Dermatology
Fountain Valley, California · Recruiting
MedDerm Associates
San Diego, California · Recruiting
Clinical Trials Research Institute
Thousand Oaks, California · Recruiting
Encore Medical Research
Hollywood, Florida · Recruiting
Mayo Clinic Jacksonville
Jacksonville, Florida · Recruiting
Miami Derm and Laser Institute
Miami, Florida · Recruiting
Global Clinical Professionals
St. Petersburg, Florida · Recruiting
Endeavor Health
Glenview, Illinois · Recruiting
Dawes Fretzin Clinical Rea Group
Indianapolis, Indiana · Recruiting
DermAssociates LLC
Rockville, Maryland · Recruiting
Uni Of Michigan Health System
Ann Arbor, Michigan · Recruiting
Hamzavi Dermatology
Fort Gratiot, Michigan · Recruiting
Revival Research Institute
Troy, Michigan · Recruiting
Skin Specialists PC
Omaha, Nebraska · Recruiting
Las Vegas Dermatology
Las Vegas, Nevada · Recruiting
Equity Medical
The Bronx, New York · Recruiting
Oregon Medical Research Center
Portland, Oregon · Recruiting
International Clinical Research Tennessee LCC
Murfreesboro, Tennessee · Recruiting
Bellaire Dermatology Associates
Bellaire, Texas · Recruiting
Center for Clinical Studies
Houston, Texas · Recruiting
Austin Inst for Clinical Research
Pflugerville, Texas · Recruiting
ACRC Trials
Plano, Texas · Recruiting
Virginia Clinical Research
Norfolk, Virginia · Recruiting
Novartis Investigative Site
Caba, Argentina · Recruiting
Novartis Investigative Site
San Miguel de Tucumán, Argentina · Recruiting
Novartis Investigative Site
Buenos Aires, Buenos Aires, Argentina · Recruiting
Novartis Investigative Site
Caba, Buenos Aires, Argentina · Recruiting
Novartis Investigative Site
CABA, Buenos Aires, Argentina · Recruiting
Novartis Investigative Site
Rosario, Santa Fe Province, Argentina · Recruiting
Novartis Investigative Site
Sydney, New South Wales, Australia · Recruiting
Novartis Investigative Site
Waitara, New South Wales, Australia · Recruiting
Novartis Investigative Site
Melbourne, Victoria, Australia · Recruiting
Novartis Investigative Site
Calgary, Alberta, Canada · Recruiting
Novartis Investigative Site
Winnipeg, Manitoba, Canada · Recruiting
Novartis Investigative Site
Mississauga, Ontario, Canada · Recruiting
Novartis Investigative Site
Newmarket, Ontario, Canada · Recruiting
Novartis Investigative Site
Toronto, Ontario, Canada · Recruiting
Novartis Investigative Site
Québec, Quebec, Canada · Recruiting
Novartis Investigative Site
Beijing, China · Recruiting
Showing 40 of 85 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.